<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>lysophosphatidylcholine (LPC 20:3) is_biomarker_for Metastatic Colorectal Cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>lysophosphatidylcholine (LPC 20:3)</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Metastatic Colorectal Cancer</strong>
</div>
<div class="entity-id">HMDB:HMDB0010384 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 6.70<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 12 citations: <strong>6.70</strong><br><span style="color:#888">7&times; extends (+4.20) &middot; 5&times; supports (+2.50)</span><br>Neighbourhood: 9.05</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.1038/s41598-019-55952-8">10.1038/s41598-019-55952-8</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 12 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:71px"></span><span>5</span><span class="cite-subtotal">&middot; +2.50</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">urinary metabolite panel (3-metabolite logistic regression model) — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/1efa518a74ab1769.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glycolysis metabolites (urinary) — increases → colorectal cancer stage progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d22d8e7058c10fd9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">amino acid metabolites (urinary) — increases → colorectal cancer stage progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/518b636a33cb6de7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">urea cycle metabolites (urinary) — increases → colorectal cancer stage progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6d2e8cc1bd2045ad.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">polyamine pathway metabolites (urinary) — increases → colorectal cancer stage progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/e466b2212b92bb78.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>7</span><span class="cite-subtotal">&middot; +4.20</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Colorectal cancer — causes → death</span><span class="cite-claim-weight">+0.60</span><a href="../claim/2210739709380dcd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">urinary metabolite panel (3-metabolite logistic regression model) — distinguishes → colorectal polyps</span><span class="cite-claim-weight">+0.60</span><a href="../claim/360f441be36300ea.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">urinary charged metabolites — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8edb3524b50bc1c2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TCA cycle metabolites (urinary) — increases → colorectal cancer stage progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/90ab8fd78369826b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">DNA methylation — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/d1fe89a5c42232d1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">microRNA — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/f25cb0e88b0f6688.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal hemoglobin — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b7e485cb03d43c01.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>aa8d23c580c49512</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0010384">HMDB:HMDB0010384</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
